UK Court Revokes 2 Novartis Patents In Bone Drug Row
A U.K. court on Friday revoked two European patents for zoledronate, agreeing with generic-drug makers Hospira UK Ltd. and Mylan Inc. that Novartis AG wasn't the first to discover its effectiveness...To view the full article, register now.
Already a subscriber? Click here to view full article